Jump to content

Coronary artery bypass surgery: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Pilarian (talk | contribs)
23 edits
Line 129: Line 129:
*[http://www.bbc.co.uk/tees/content/articles/2008/11/21/jeffrey_bypass_feature.shtml A BBC film showing a patient undergoing a double bypass operation.]
*[http://www.bbc.co.uk/tees/content/articles/2008/11/21/jeffrey_bypass_feature.shtml A BBC film showing a patient undergoing a double bypass operation.]
*[http://cardiacsurgery.ctsnetbooks.org/current.shtml#PART_III__ISCHEMIC_HEART_DISEASE Ischemic Heart Disease] section in ''Cardiac Surgey in the Adult''
*[http://cardiacsurgery.ctsnetbooks.org/current.shtml#PART_III__ISCHEMIC_HEART_DISEASE Ischemic Heart Disease] section in ''Cardiac Surgey in the Adult''
*[http://thevisualmd.com/health_centers/cardiovascular_health/coronary_bypass_surgery TheVisualMD] - Learn more on how coronary bypass surgery is being performed through visualizations and video.


<BR>
<BR>

Revision as of 16:17, 13 November 2009

"Heart bypass" redirects here. For the technique to take over the function of the heart and lungs during surgery, see Cardiopulmonary bypass.
Early in a coronary artery bypass surgery during vein harvesting from the legs (left of image) and the establishment of bypass (placement of the aortic cannula) (bottom of image). The perfusionist and heart-lung machine (HLM) are on the upper right. The patient's head (not seen) is at the bottom.
Coronary artery bypass surgery during mobilization (freeing) of the right coronary artery from its surrounding tissue, adipose tissue (yellow). The tube visible at the bottom is the aortic cannula (returns blood from the HLM). The tube above it (obscured by the surgeon on the right) is the venous cannula (receives blood from the body). The patient's heart is stopped and the aorta is cross-clamped. The patient's head (not seen) is at the bottom.
Heart saphenous coronary grafts

Coronary artery bypass surgery, also coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery is a surgical procedure performed to relieve angina and reduce the risk of death from coronary artery disease. Arteries or veins from elsewhere in the patient's body are grafted to the coronary arteries to bypass atherosclerotic narrowings and improve the blood supply to the coronary circulation supplying the myocardium (heart muscle). This surgery is usually performed with the heart stopped, necessitating the usage of cardiopulmonary bypass; techniques are available to perform CABG on a beating heart, so-called "off-pump" surgery.

History

The first coronary artery bypass surgery was performed in the United States on May 2, 1960 at the Albert Einstein College of Medicine-Bronx Municipal Hospital Center by a team led by Dr. Robert Goetz and the thoracic surgeon, Dr. Michael Rohman with the assistance of Dr. Jordan Haller and Dr. Ronald Dee.[1][2] But in this technique the vessels are held together with circumferential ligatures over an inserted metal ring. The internal mammary artery was used as the donor vessel and was anastomosed to the right coronary artery. The actual anastomosis with the Rosenbach ring took fifteen seconds and did not require Cardio-Pulmonary bypass. The disadvantage of using the internal mammary artery was that, at autopsy nine months later, the anastomosis was open, but an atheromatous plaque had occluded the origin of the internal mammary that was used for the bypass.

The Russian cardiac surgeon, Dr Vasilii Kolesov, performed arguably the first successful coronary artery anastomosis in 1964 [3]

This technique was quickly superseded by Dr. René Favaloro who pioneered the bypass grafting procedure in 1967 [4] His new technique used a saphenous vein autograft to replace a stenotic segment of the right coronary artery. He later began to use the saphenous vein as a bypassing channel and become instantly successful. This is the typical bypass graft technique we know today. Soon Dr Dudley Johnson extended the bypass to include left coronary arterial systems. [3] In 1968, Doctors Charles Bailey, Teruo Hirose and George Green used the internal mammary artery instead of the saphenous vein for the grafting. [3]

Terminology

There are many variations on terminology, in which one or more of 'artery', 'bypass' or 'graft' is left out. The most frequently used acronym for this type of surgery is CABG (pronounced 'cabbage'),[5] pluralized as CABGs (pronounced 'cabbages'). More recently the term aortocoronary bypass (ACB) has come into popular use. CAGS (Coronary Artery Graft Surgery, pronounced phonetically) should not be confused with Coronary Angiography (CAG).

Arteriosclerosis is a common arterial disorder characterized by thickening, loss of elasticity, and calcification of arterial walls, resulting in a decreased blood supply.

Atherosclerosis is a common arterial disorder characterized by yellowish plaques of cholesterol, lipids, and cellular debris in the inner layer of the walls of large and medium-sized arteries.

Number of bypasses

The terms single bypass, double bypass, triple bypass, quadruple bypass and quintuple bypass refer to the number of coronary arteries bypassed in the procedure. In other words, a double bypass means two coronary arteries are bypassed (e.g. the left anterior descending (LAD) coronary artery and right coronary artery (RCA)); a triple bypass means three vessels are bypassed (e.g. LAD, RCA, left circumflex artery (LCX)); a quadruple bypass means four vessels are bypassed (e.g. LAD, RCA, LCX, first diagonal artery of the LAD) while quintuple means five. Bypass of more than four coronary arteries is uncommon.

A greater number of bypasses does not imply a person is "sicker," nor does a lesser number imply a person is "healthier."[6] A person with a large amount of coronary artery disease (CAD) may receive fewer bypass grafts owing to the lack of suitable "target" vessels. A coronary artery may be unsuitable for bypass grafting if it is small (< 1 mm or < 1.5 mm depending on surgeon preference), heavily calcified (meaning the artery does not have a section free of CAD) or intramyocardial (the coronary artery is located within the heart muscle rather than on the surface of the heart). Similarly, a person with a single stenosis ("narrowing") of the left main coronary artery requires only two bypasses (to the LAD and the LCX). However, a left main lesion places a person at the highest risk for death from a cardiac cause.[citation needed]

The surgeon reviews the coronary angiogram prior to surgery and identifies the lesions (or "blockages") in the coronary arteries. The surgeon will estimate the number of bypass grafts prior to surgery, but the final decision is made in the operating room upon examination of the heart.

Indications for CABG

Several alternative treatments for coronary artery disease exist. They include:

Both PCI and CABG are more effective than medical management at relieving symptoms,[7] (e.g. angina, dyspnea, fatigue). CABG is superior to PCI for some patients with multivessel CAD[8][9]

The Surgery or Stent (SoS) trial was a randomized controlled trial that compared CABG to PCI with bare-metal stents. The SoS trial demonstrated CABG is superior to PCI in multivessel coronary disease.[8]

The SYNTAX trial was a randomized controlled trial of 1800 patients with multivessel coronary disease, comparing CABG versus PCI using drug-eluting stents (DES). The study found that rates of major adverse cardiac or cerebrovascular events at 12 months were significantly higher in the DES group (17.8% versus 12.4% for CABG; P=0.002). [9] This was primarily driven by higher need for repeat revascularization procedures in the PCI group with no difference in repeat infarctions or survival. Higher rates of strokes were seen in the CABG group.

The FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus—Optimal Management of Multivessel Disease) trial will compare CABG and DES in patients with diabetes. The registries of the nonrandomized patients screened for these trials may provide as much robust data regarding revascularization outcomes as the randomized analysis.[10]

A study comparing the outcomes of all patients in New York state treated with CABG or percutaneous coronary intervention (PCI) demonstrated CABG was superior to PCI with DES in multivessel (more than one diseased artery) coronary artery disease (CAD). Patients treated with CABG had lower rates of death and of death or myocardial infarction than treatment with a coronary stent. Patients undergoing CABG also had lower rates of repeat revascularization.[11] The New York State registry included all patients undergoing revascularization for coronary artery disease, but was not a randomized trial, and so may have reflected other factors besides the method of coronary revascularization.

The 2004 ACC/AHA CABG guidelines state CABG is the preferred treatment for:[12]

The 2005 ACC/AHA guidelines further state: CABG is the likely the preferred treatment with other high-risk patients such as those with severe ventricular dysfunction (i.e. low ejection fraction), or diabetes mellitus.[12]

Prognosis

Prognosis following CABG depends on a variety of factors, but successful grafts typically last around 10–15 years. In general, CABG improves the chances of survival of patients who are at high risk (meaning those presenting with angina pain shown to be due to ischemic heart disease), but statistically after about 5 years the difference in survival rate between those who have had surgery and those treated by drug therapy diminishes. Age at the time of CABG is critical to the prognosis, younger patients with no complicating diseases have a high probability of greater longevity. The older patient can usually be expected to suffer further blockage of the coronary arteries.[citation needed]

Procedure (Simplified)

  1. The patient is brought to the operating room and moved on to the operating table.
  2. An anaesthetist places a variety of intravenous lines and injects an induction agent (usually propofol) to render the patient unconscious.
  3. An endotracheal tube is inserted and secured by the anaesthetist or assistant (e.g. respiratory therapist or nurse anaesthetist) and mechanical ventilation is started.
  4. The chest is opened via a median sternotomy and the heart is examined by the surgeon.
  5. The bypass grafts are harvested - frequent conduits are the internal thoracic arteries, radial arteries and saphenous veins. When harvesting is done, the patient is given heparin to prevent the blood from clotting.
  6. In the case of "off-pump" surgery, the surgeon places devices to stabilize the heart.
  7. If the case is "on-pump", the surgeon sutures cannulae into the heart and instructs the perfusionist to start cardiopulmonary bypass (CPB). Once CPB is established, the surgeon places the aortic cross-clamp across the aorta and instructs the perfusionist to deliver cardioplegia to stop the heart.
  8. One end of each graft is sewn on to the coronary arteries beyond the blockages and the other end is attached to the aorta.
  9. The heart is restarted; or in "off-pump" surgery, the stabilizing devices are removed. In some cases, the Aorta is partially occluded by a C-shaped clamp, the heart is restarted and suturing of the grafts to the aorta is done in this partially occluded section of the aorta while the heart is beating.
  10. Protamine is given to reverse the effects of heparin.
  11. The sternum is wired together and the incisions are sutured closed.
  12. The patient is moved to the intensive care unit (ICU) to recover. After awakening and stabilizing in the ICU (approximately 1 day), the person is transferred to the cardiac surgery ward until ready to go home (approximately 4 days).

Minimally Invasive CABG

Alternate methods of minimally invasive coronary artery bypass surgery have been developed in recent times. Off-pump coronary artery bypass surgery (OPCAB) is a technique of performing bypass surgery without the use of cardiopulmonary bypass (the heart-lung machine). Further refinements to OPCAB have resulted in minimally invasive direct coronary artery bypass surgery (MIDCAB), a technique of performing bypass surgery through a 5 to 10 cm incision.

Conduits used for bypass

The choice of conduits is highly dependent upon the particular surgeon and institution. Typically, the left internal thoracic artery (LITA) (previously referred to as left internal mammary artery or LIMA) is grafted to the left anterior descending artery and a combination of other arteries and veins is used for other coronary arteries. The right internal thoracic artery (RITA), the great saphenous vein from the leg and the radial artery from the forearm are frequently used. The right gastroepiploic artery from the stomach is infrequently used given the difficult mobilization from the abdomen.

Graft patency

Grafts can become diseased and may occlude in the months to years after bypass surgery is performed. Patency is a term used to describe the chance that a graft remain open. A graft is considered patent if there is flow through the graft without any significant (>70% diameter) stenosis in the graft.

Graft patency is dependent on a number of factors, including the type of graft used (internal thoracic artery, radial artery, or great saphenous vein), the size or the coronary artery that the graft is anastomosed with, and, of course, the skill of the surgeon(s) performing the procedure. Arterial grafts (e.g. LITA, radial) are far more sensitive to rough handling than the saphenous veins and may go into spasm if handled improperly.

Generally the best patency rates are achieved with the in-situ (the proximal end is left connected to the subclavian artery) left internal thoracic artery with the distal end being anastomosed with the coronary artery (typically the left anterior descending artery or a diagonal branch artery). Lesser patency rates can be expected with radial artery grafts and "free" internal thoracic artery grafts (where the proximal end of the thoracic artery is excised from its origin from the subclavian artery and re-anastomosed with the ascending aorta). Saphenous vein grafts have worse patency rates, but are more available, as the patients can have multiple segments of the saphenous vein used to bypass different arteries.

Veins that are used either have their valves removed or are turned around so that the valves in them do not occlude blood flow in the graft. LITA grafts are longer-lasting than vein grafts, both because the artery is more robust than a vein and because, being already connected to the arterial tree, the LITA need only be grafted at one end. The LITA is usually grafted to the left anterior descending coronary artery (LAD) because of its superior long-term patency when compared to saphenous vein grafts.[13][14]

Sternal Precautions

Patients undergoing coronary artery bypass surgery will have to avoid certain things for eight to 12 weeks to reduce the risk of opening the incision. These are called sternal precautions. First, patients need to avoid using their arms excessively, such as pushing themselves out of a chair or reaching back before sitting down. To avoid this, patients are encouraged to build up momentum by rocking several times in their chair before standing up. Second, patients should avoid lifting anything in excess of 5-10 pounds. A gallon (U.S.) of milk weighs approximately 8.5 pounds, and is a good reference point for weight limitations. Finally, patients should avoid overhead activities with their hands, such as reaching for sweaters from the top shelf of a closet or reaching for plates or cups from the cupboard.

Complications

People undergoing coronary artery bypass are at risk for the same complications as any surgery, plus some risks more common with or unique to CABG.

CABG associated

General surgical

Randomized Controlled Trial (RCT) including Placebo

While there have been a handful of RCTs[8][9] comparing CABG with other surgical procedures, an exhaustive review of the medical literature reported in 2002 found no RCT had ever been conducted to demonstrate the efficacy of CABG to that of placebo.[16] In fact, as Daniel Moerman has pointed out the combined results of two RCTs comparing an earlier surgical procedure for angina - bilateral internal mammary artery ligation (BIMAL) - to a sham surgery clearly show that patients "experienced significant subjective improvement," with both BIMAL (67% substantial improvement) and the sham procedure (82% substantial improvement).[17] Surgery as a meaningful experience (placebo effect) was most likely the cause of improvement for patients in both of these studies with the sham surgical procedure actually proving slightly more effective.

See also

References

  1. ^ Dee R (2003). "Who assisted whom?". Tex Heart Inst J. 30 (1): 90. PMC 152850. PMID 12638685.
  2. ^ Haller JD, Olearchyk AS (2002). "Cardiology's 10 greatest discoveries". Tex Heart Inst J. 29 (4): 342–4. PMC 140304. PMID 12484626.
  3. ^ a b c Nirav J. Mehta, MD and Ijaz A. Khan, MD Houston Division of Cardiology, Creighton University School of Medicine, Omaha, Nebraska 68131,"Cardiology's 10 Greatest Discoveries of the 20th Century", FACC, 2002, Texas Heart Institute Journal, 29(3):164-171, accessed online on 2 Jan 2009 at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=124754
  4. ^ Nirav J. Mehta, MD and Ijaz A. Khan, MD Houston Division of Cardiology, Creighton University School of Medicine, Omaha, Nebraska 68131,"Cardiology's 10 Greatest Discoveries of the 20th Century", FACC, 2002, Texas Heart Institute Journal, 29(3):164-171, accessed online on 2 Jan 2009 at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=124754
  5. ^ American Heart Association. Heart Bypass Surgery. URL: http://www.americanheart.org/presenter.jhtml?identifier=4484. Accessed on March 26, 2006.
  6. ^ Ohki S, Kaneko T, Satoh Y; et al. (2002). "[Coronary artery bypass grafting in octogenarian]". Kyobu geka. The Japanese journal of thoracic surgery (in Japanese). 55 (10): 829–33, discussion 833–6. PMID 12233100. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  7. ^ Rihal C, Raco D, Gersh B, Yusuf S (2003). "Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations". Circulation. 108 (20): 2439–45. doi:10.1161/01.CIR.0000094405.21583.7C. PMID 14623791.{{cite journal}}: CS1 maint: multiple names: authors list (link) Full Free Text.
  8. ^ a b c SoS Investigators (2002). "Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial". Lancet. 360 (9338): 965–70. doi:10.1016/S0140-6736(02)11078-6. PMID 12383664.
  9. ^ a b c Serruys PW, Morice M-C, Kappetein AP; et al. (2009). "Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease". N Engl J Med. doi:10.1056/NEJMoa0804626. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  10. ^ Desai ND (2008). "Pitfalls assessing the role of drug-eluting stents in multivessel coronary disease". Ann. Thorac. Surg. 85 (1): 25–7. doi:10.1016/j.athoracsur.2007.08.063. PMID 18154771.
  11. ^ Hannan EL, Wu C, Walford G; et al. (2008). "Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease". N. Engl. J. Med. 358 (4): 331–41. doi:10.1056/NEJMoa071804. PMID 18216353. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  12. ^ a b Eagle KA, Guyton RA, Davidoff R; et al. (2004). "ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery)". Circulation. 110 (14): e340–437. PMID 15466654. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  13. ^ Kitamura S, Kawachi K, Kawata T, Kobayashi S, Mizuguchi K, Kameda Y, Nishioka H, Hamada Y, Yoshida Y. [Ten-year survival and cardiac event-free rates in Japanese patients with the left anterior descending artery revascularized with internal thoracic artery or saphenous vein graft: a comparative study] Nippon Geka Gakkai Zasshi. 1996 Mar;97(3):202-9. PMID 8649330.
  14. ^ Arima M, Kanoh T, Suzuki T, Kuremoto K, Tanimoto K, Oigawa T, Matsuda S. Serial Angiographic Follow-up Beyond 10 Years After Coronary Artery Bypass Grafting. Circ J. 2005 Aug;69(8):896-902. PMID 16041156. Free Full Text.
  15. ^ http://www.scientificamerican.com/article.cfm?id=disease-may-cause-pumphead
  16. ^ Moerman, Daniel. 2002. Meaning, Medicine and the "Placebo Effect". New York: Cambridge University Press. Pg.60 [1]
  17. ^ Moerman, Daniel. 2002. Meaning, Medicine and the "Placebo Effect". New York: Cambridge University Press. Pg.58 [2]


Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Coronary_artery_bypass_surgery&oldid=325639256"